Episode 54: CRP - An important part of a Comprehensive Risk Profile or a Completely Ridiculous Practice- Part III
Submitted by JPM on Wed, 2009-06-10 20:00.
Episode 54 finishes off the whole issue of CRP measurement by looking at the evidence we have about what happens to patients when they take drugs that lower CRP - glitazones, COX-2s, fibrates, vitamin E, niacin, ezetimibe, and statins. Other than statins and maybe niacin, it doesn't look good - in contrast to Mike and James of course that is.